Ignite Creation Date:
2025-12-25 @ 12:30 AM
Ignite Modification Date:
2026-01-20 @ 3:28 AM
Study NCT ID:
NCT00871767
Status:
COMPLETED
Last Update Posted:
2009-06-30
First Post:
2009-03-26
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
AZD5672 Bioavailability Study in Healthy Male and Female Subjects
Sponsor:
AstraZeneca
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
D1710C00019
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
Mark Layton, MD, PhD, Medical Science Director
Old Organization:
AstraZeneca